Notice Number: NOT-AG-19-013
Key Dates
Release Date: March 25, 2019
RFA-AG-20-004
Issued by
National Institute on Aging (NIA)
Purpose
The purpose of this Notice is to inform interested applicants that the application types allowed for Funding Opportunity Announcement (FOA) RFA-AG-20-004 “Alzheimer's Disease Research Centers (P30 Clinical Trial Not Allowed)" have been modified to include only New applications.
Currently Reads:
Part 2, Section II, Award Information
Application Types Allowed: New, Resubmission, Renewal
Part 2, Section V. Application Review Information
1. Criteria
Resubmissions
For Resubmissions, the committee will evaluate the application as now presented, taking into consideration the responses to comments from the previous scientific review group and changes made to the project.
Renewals
For Renewals, the committee will consider the progress made in the last funding period.
Revisions
Not Applicable
Revised to Read:
Part 2, Section II, Award Information
Application Types Allowed: New
Part 2, Section V. Application Review Information
1. Criteria
Resubmissions
Not Applicable
Renewals
Not Applicable
Revisions
Not Applicable
In addition, reflecting this change in application types, an "Introduction to Application" section is no longer allowed for the components of the announcement.
All other aspects of the FOA remain unchanged.
Inquiries
Please direct all inquiries to:
Cerise L. Elliott, Ph.D.
National Institute on Aging (NIA)
Telephone: 301-496-9350
Email: elliottce@nih.gov
and Human Services (HHS)
